Boothbay Fund Management, LLC Applied Genetic Technologies Corp Transaction History

Boothbay Fund Management, LLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$0.62 - $1.1 $24,150 - $42,848	-38,953 Closed	0 $0
Q3 2021 Nov 15, 2021	SELL	$3.01 - $4.12 $101,915 - $139,499	-33,859 Reduced 46.5%	38,953 $117,000
Q2 2021 Aug 16, 2021	SELL	$3.62 - $5.23 $42,104 - $60,830	-11,631 Reduced 13.77%	72,812 $285,000
Q1 2021 May 17, 2021	SELL	$3.94 - $8.19 $563 - $1,171	-143 Reduced 0.17%	84,443 $428,000
Q1 2020 May 15, 2020	BUY	$2.36 - $9.86 $103,915 - $434,155	44,032 Added 108.58%	84,586 $277,000
Q3 2019 Nov 14, 2019	SELL	$2.59 - $4.16 $11,880 - $19,081	-4,587 Reduced 10.16%	40,554 $169,000
Q1 2019 May 15, 2019	BUY	$2.62 - $4.44 $118,269 - $200,426	45,141 New	45,141 $189,000
Q4 2018 Feb 14, 2019	SELL	$2.28 - $7.15 $133,694 - $419,261	-58,638 Closed	0 $0
Q3 2018 Nov 14, 2018	BUY	$3.85 - $7.35 $75,729 - $144,574	19,670 Added 50.48%	58,638 $428,000
Q2 2018 Aug 14, 2018	BUY	$3.7 - $5.65 $144,181 - $220,169	38,968 New	38,968 $144,000

Ticker AGTC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 67,632,200
Description
Applied Genetic Technologies Corporation, a clinical-stage biotechnology company, develops transformational genetic therapies for patients suffering from rare and debilitating diseases. Its advanced product candidates include three ophthalmology development programs across two targets, including X-linked retinitis pigmentosa, which is in the Pha...

Get notified when there are updates to the investment portfolio of Boothbay Fund Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Boothbay Fund Management, LLC with notifications on news.